Medicine for treating type-II diabetes and complications thereof and preparation method thereof

Abstract

The invention discloses a medicine for treating type-II diabetes and complications thereof and a preparation method thereof, and relates to the technical field of diabetes treating medicines. The medicine comprises the following raw materials in parts by weight: 15-25 parts of pseudoginseng, 15-25 parts of dendrobium, 15-25 parts of kudzu vine roots, 20-30 parts of bittergourd, 10-20 parts of schisandra chinensis, 15-25 parts of American ginseng, 7-15 parts of fructus cnidii, 7-15 parts of ligusticum wallichii, 7-15 parts of mangnolia officinalis, 15-25 parts of dwarf lilyturf tuber, 10-20 parts of rhizoma atractylodis and 10-20 parts of scutellaria baicalensis. Through reasonable compatibility of the raw materials which complement one another, the medicine achieves the efficacies of clearing away heat, promoting secretion of body fluid, tonifying kidney, strengthening spleen, nourishing Yin and eliminating dryness, can dilate blood vessels, improve human immunity, effectively regulatethe sensitivity of a human body to insulin and play a role in regulating blood sugar, can alleviate and treat the related complications on the basis of reducing the blood sugar, has a significant blood sugar lowering effect, has a high effective rate, and has a small side effect of damaging the human liver and other organs; the preparation method is simple and easy to implement and popularize.

Description

technical field [0001] The invention relates to the technical field of diabetes drugs, in particular to a drug for treating type II diabetes and its complications and a preparation method thereof. Background technique [0002] Diabetes mellitus is a chronic endocrine and metabolic disease characterized by hyperglycemia. Its pathological basis is absolute and / or relative lack of insulin, which in turn causes a series of metabolic disorders of sugar, fat, protein, water and electrolytes. The number of people with diabetes in the world is as high as 422 million, and 1 in 11 people suffer from diabetes. my country has become the world's largest diabetes country, with one-third of the world's patients, and about 1.5 million new patients each year, of which about 97% are type Ⅱ diabetes patients. Diabetes has become the third chronic disease that seriously endangers human health after tumors and cardiovascular and cerebrovascular diseases, and is called "the disaster of the 21st ...

AI Technical Summary

Problems solved by technology

The curative effect of oral hypoglycemic drugs such as xanthylureas and biguanides is worthy of recognition, but long-term oral hypoglycemic drugs may cause side effects such as gastrointestinal reactions, liver and kidney damage, and cannot effectively control complications

Long-term use will also cause the accumulation of drug toxins in the body, accelerate the development of diabetic complications, aggravate the condition of diabetes, and make patients worse

Images